Transplant

LenaRIC

LenaRIC -  Phase II study of the adjunctive use of Lenalidomide in patients undergoing reduced intensity conditioning allogenic transplantation for multiple myeloma.

Genetic Factors MUD

Genetic factors affecting the outcome of unrelated stem cell transplantation. Primary Objective: To identify a significant correlation between genetic factors found in the donor or the recipients blood and transplant outcome. Secondary Objectives: To maintain a database of genetic typing to supplement the existing database kept by the registry

ProT4

Prophylactic Transfer of CD4 Lymphocytes (ProT4) A Multicentre randomised phase II study to evaluate the efficacy of prophylactic transfer of CD4 lymphocytes after T-cell depleted reduced intensity HLA-identical sibling transplantation for haematological cancer

UK Haplo

 

A UK multicentre phase II study of haploidentical stem cell transplantation in patients with haematological malignancies

Figaro

 

A Randomised Trial of the FLAMSA-BU CondItioning ReGimen in Patients with Acute Myeloid Leukaemia and Myelodysplasia UndeRgoing AllOgeneic Stem Cell Transplantation